{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:43:47Z","timestamp":1747172627605,"version":"3.40.5"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.yrtph.2024.105617","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T16:17:34Z","timestamp":1711815454000},"page":"105617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["False positive findings associated with adenoviral vector-based vaccine underscore the regulatory necessity to eliminate abnormal toxicity test"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-0070","authenticated-orcid":false,"given":"Ryan","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"van Ooij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Chinese Pharmacopoeia 2020 - English","key":"10.1016\/j.yrtph.2024.105617_bib1"},{"issue":"2","key":"10.1016\/j.yrtph.2024.105617_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/hv.22847","article-title":"An improved whole cell pertussis vaccine with reduced content of endotoxin","volume":"9","author":"Dias","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"year":"2017","series-title":"Strasbourg, France. Suppression of the Test for Abnormal Toxicity from the European Pharmacopoeia","key":"10.1016\/j.yrtph.2024.105617_bib3"},{"year":"2023","series-title":"European Pharmacopoeia (11.0)","key":"10.1016\/j.yrtph.2024.105617_bib4"},{"key":"10.1016\/j.yrtph.2024.105617_bib6","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1002\/jps.24125","article-title":"Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test","volume":"103","author":"Garbe","year":"2014","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.yrtph.2024.105617_bib7","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.vaccine.2014.02.021","article-title":"Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products","volume":"32","author":"Gombold","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.yrtph.2024.105617_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biologicals.2008.07.007","article-title":"An improved abnormal toxicity test by using reference vaccine-specific body weight curves and histopathological data for monitoring vaccine quality and safety in Japan","volume":"37","author":"Mizukami","year":"2019","journal-title":"Biologicals"},{"year":"2018","series-title":"Russia State Pharmacopoeia","key":"10.1016\/j.yrtph.2024.105617_bib10"},{"key":"10.1016\/j.yrtph.2024.105617_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2022.06.003","article-title":"Accelerating global deletion of the abnormal toxicity test for vaccines and biologicals. Planning common next steps. A workshop report","volume":"78","author":"Viviani","year":"2022","journal-title":"Biologicals"},{"key":"10.1016\/j.yrtph.2024.105617_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biologicals.2019.10.007","article-title":"Global harmonization of vaccine testing requirements: making elimination of the ATT and TABST a concrete global achievement","volume":"63","author":"Viviani","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.yrtph.2024.105617_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yrtph.2015.09.033","article-title":"Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias","volume":"73","author":"Xie","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230024000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T13:19:44Z","timestamp":1717766384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230024000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":11,"alternative-id":["S0273230024000588"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105617","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"False positive findings associated with adenoviral vector-based vaccine underscore the regulatory necessity to eliminate abnormal toxicity test","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2024.105617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105617"}}